Sort
130,381 grants matching “hiv”
The Youth Opioid Recovery Support (YORS) Intervention: An assertive community treatment model for improving medication adherence in young adults with opioid use disorder
$2,465,674Marc Fishman · Maryland Treatment Centers, Inc. · R33 · FY2021 · DA
Optimizing Human B and T Cell Vaccines Against HIV Using Humanized BLT Mice
$2,465,248Todd M Allen · Massachusetts General Hospital · P01 · FY2014 · AI
Health Department Demonstration Projects for Comprehensive Prevention, Care, Behavioral Health & Social Services for Men Who Have Sex with Men (MSM) of Color at Risk for and Living with HIV Infection
$2,465,000Michael Dustin Shankle · Health Hiv · U65 · FY2015 · PS
IMMUNOLOGICAL AND VIROLOGICAL EVENTS IN EARLY HIV INFECTION
$2,464,650James Ivan Mullins · University Of Washington · P01 · FY2012 · AI
Malaria immunology
$2,464,408Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$2,464,363Pablo Tebas · University Of Pennsylvania · UM1 · FY2020 · AI
Development of Novel Therapies for HIV Infection and AIDS-Related Malignancies
$2,463,925Robert Yarchoan · Clinical Sciences · Z01 · FY2007 · CA
HIV/SIV Database and Analysis Unit
$2,463,763National Institute Of Allergy And Infectious Diseases · Y01 · FY2011 · AI
IMMUNOLOGICAL AND VIROLOGICAL EVENTS IN EARLY HIV INFECTION
$2,462,710James Ivan Mullins · University Of Washington · P01 · FY2014 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$2,462,528Judith S. Currier · University Of California Los Angeles · U01 · FY2010 · AI
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV
$2,461,914Manolis Kellis · Broad Institute, Inc. · U01 · FY2021 · DA
A Compartmental Analysis of HIV Reservoirs and Immune Reconstitution
$2,461,908Timothy W Schacker · University Of Minnesota · P01 · FY2008 · AI
Optimizing Human B and T Cell Vaccines Against HIV Using Humanized BLT Mice
$2,461,800Todd M Allen · Massachusetts General Hospital · P01 · FY2015 · AI
Estrogen's Impact on IgG Glycomic Modulation of Immunity and Inflammation During HIV
$2,461,651Jordan E Lake · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · AI
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,461,018Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Taking Our Shot: Extended-Release Naltrexone as Opioid Overdose Pre-Exposure Prophylaxis (PrEP) in People Using Stimulants Living With or At Risk of HIV
$2,460,000Ayesha A Appa · University Of California, San Francisco · DP2 · FY2024 · DA
PS09-962: SUPP. THE IMP. AND EXPANSION OF HIGH QUALITY HIV PREVENTION,CARE A
$2,459,813Dr. Anthony Amoroso · University Of Maryland Baltimore · U2G · FY2012 · PS
Vascular Subphenotypes of Lung Disease
$2,459,371Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2015 · HL
Emory WIHS CRS - Longitudinal Cohort
$2,458,733Ighovwerha Ofotokun · Emory University · U01 · FY2014 · AI
Optimizing Human B and T Cell Vaccines Against HIV Using Humanized BLT Mice
$2,458,248Todd M Allen · Massachusetts General Hospital · P01 · FY2016 · AI
PS10-1001, HIV PREVENTION PROJECTS
$2,458,034Veda M Latin · Public Health Services · U62 · FY2011 · PS
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network
$2,457,513T John Winhusen · University Of Cincinnati · UG1 · FY2019 · DA
A NOVEL VEE REPLICON VACCINE FOR HIV
$2,456,857University Of North Carolina Chapel Hill · P01 · FY2001 · AI
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$2,456,823Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Feasibility for Development of a Liposome/LNP Displaying an HIV Env Trimer Protein and Containing/Incorporating an mRNA
$2,456,817Duke University · N01 · FY2024 · AI